In the CLL LN ENO1 reactivity was mostly associated to the CD23+ population, while in the R LN it was mostly associated to the CD2+ T cells (Figure 3C–3E). This evidence concerns the gene FCER2 and B-cell chronic lymphocytic leukemia.